Remove 2016 Remove COVID-19 Vaccine Remove FDA Remove Licensing
article thumbnail

Health Provider News

Hall Render

after cyberattack CHI St. migrants are a housing challenge. NEW HAMPSHIRE Ambulance service in N.H. The Triangle’s health outcomes rank among highest in the nation What HCA has told feds it’s doing to fix staffing issues at Mission Hospital. Here’s how S.C. Here’s how S.C.

article thumbnail

Health Provider News

Hall Render

Joe’s among busiest hospital ERs in nation, poll reveals New ASC, medical building proposed in New Jersey New Jersey hospital innovation director appointed to FDA committee New Jersey hospital rebuffs criticism from US senator Nurses testify that N.J. Then Prospect Medical took over.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News

Hall Render

Supreme Court won’t hear COVID vaccine case filed by N.J. Grifols gets FDA approval for new facility in Clayton Invitae pledged $115M, 374-job investment in North Carolina. million patients stolen during ransomware attack MINNESOTA CFO of the Year 2023: Penny Cermak, HealthPartners Inc. Many more are waiting.

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

Since the FDA requires pre-approval of any warnings about off-label uses, preemption at some point should have been pre-ordained under the Mensing ( 2011+1 ) independence principle, but off-label use did not really figure in Zofran ’s analysis. The FDA’s five reviews of teratogenic risk all came to the same conclusion.

FDA 105
article thumbnail

A Texas Mess

Drug & Device Law

The complaint, brought under the Texas consumer protection statute, sued a major manufacturer of COVID-19 vaccine that was used to control the recent pandemic. The FDA, however, did not and does not share that belief. FDA (8/23/21) press release (emphasis original). Again, the FDA does not agree.